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Abstract
One of the main changes in the 8th edition of the American Joint Committee on Cancer (AJCC) for staging of oral cancer is the
inclusion of depth of invasion (DOI) in the T category. However, cancers in different oral subsites have variable behavior, with
oral tongue squamous cell carcinoma (OTSCC) being the most aggressive one even at early stage. Thus, it is necessary to
evaluate the performance of this new Tcategory in homogenous cohort of early OTSCC. Therefore, we analyzed a large cohort of
patients with a small (≤ 4 cm) OTSCC to demonstrate the differences in Tstage between the AJCC 7th and 8th editions. A total of
311 early-stage cases (AJCC 7th) of OTSCC were analyzed. We used 5 mm and 10 mm DOI for upstaging from T1 to T2 and
from T2 to T3 respectively, as in the AJCC 8th.We further reclassified the cases according to our own proposal suggesting 2 mm
to upstage to T2 and 4mm to upstage to T3. According to AJCC 7th, there were no significant differences in the survival analysis.
When we applied the 8th edition, many cases were upstaged to T3 and thus associated with worse disease-specific survival (HR
2.37, 95% CI 1.12–4.99) and disease-free survival (HR 2.12, 95% CI 1.09–4.08). Based on our proposal, T3 cases were
associated with even worse disease-specific survival (HR 4.19, 95% CI 2.27–7.74). The 8th edition provides better survival
prediction for OTSCC than the 7th and can be further optimized by lowering the DOI cutoffs.
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Introduction
Tumor-Node-Metastases (TNM) staging system is widely
used as a universal tool for the classification of many cancers.
TNM staging defines extent of tumor and provides prognostic
information, which is traditionally used for treatment planning
[1]. Treatment of small tumors (T1–T2) of oral tongue squa-
mous cell carcinoma (OTSCC) with clinically negative neck
(cN0) still remains a dilemma. Although such cancers are
considered at Bearly-stage^ and referred to Blow-risk,^ many
of the cT1–2N0 cases have been associated with poor prog-
nosis [2, 3]. Therefore, cTNM has been criticized over the
years for presenting low prognostic capacity for early-stage
OTSCC [4]. The main shortcoming of the T stage category is
that it describes only the tumor diameter. Thus, a small super-
ficial tumor with < 4 cm in diameter is considered (according
to the 7th edition of the American Joint Committee on Cancer,
AJCC manual [5]) at early-stage, similar to another small tu-
mor < 4 cm in diameter but with deeper invasion.
The AJCC has recently released the 8th edition of manual
for cancer staging [6]. For oral squamous cell carcinoma
(OSCC), one of the main changes in this new edition was
the incorporation of depth of invasion (DOI) in the Tcategory.
Researchers have conducted numerous studies to evaluate the
prognostic value of DOI in OSCC [3, 4, 7]. There is a wide
agreement between most of the recent studies about the im-
portance of DOI in prognostication of OSCC [3, 7, 8].
However, a debate about the optimal cutoff point remains
among the published studies. For example, cutoff points of
2 mm [9], 4 mm [3, 10], and 5 mm [11] have been used for
risk stratification. AJCC has used > 5 mm for upstaging from
T1 to T2 and > 10 mm for upstaging to T3. The aim of this
study was to demonstrate the effects of changes regarding T
stage between the AJCC 7th and 8th editions [5, 6] in a mul-
ticenter cohort of 311 cases previously identified as early stage
according to AJCC 7th edition [5].We also provide a proposal
for the future developmental work of the AJCC system to
further optimize the criteria for T category. Our proposal is
based on evidence from a meta-analysis that found 4 mm as
an optimal cutoff point [12] for risk stratification. Of note,
many subsequent studies had validated the finding of that
meta-analysis and confirmed that early OTSCC tumors deeper
than 4 mm associated with high risk of poor prognosis [3, 7,
13].
Materials and methods
This retrospective study included patients treated for OTSCC
at the five Finnish university hospitals (224 cases) and in the
A.C. Camargo Cancer Center, São Paulo, Brazil (87 cases).
According to the AJCC 7th staging (Table 1) [5], these cases
were identified as early stage (T1–T2N0); and were all
surgically treated. We used the criteria for T stage introduced
in the AJCC 8th (Table 1) [6] to re-stage these 311 cases by
including depth of invasion (DOI), which was measured as
described by the AJCC [6]. In the AJCC 8th, T1 refers to
tumors ≤ 2 cm in diameter and DOI ≤ 5 mm. T2 refers to
tumors ≤ 2 cm in diameter and DOI > 5 mm and ≤ 10 mm,
or tumors > 2 cm but ≤ 4 cm and DOI ≤ 10 mm. T3 refers to
tumors > 4 cm or any tumors with DOI > 10 mm. T4 refers to
moderately advanced or very advanced local disease.
According to the AJCC 8th, DOI does not influence the T4
stage. We also re-staged these 311 cases using our proposal
(Table 1) as follows: T1, tumor ≤ 2 cm and DOI ≤ 2 mm; T2,
tumor ≤ 2 cm and DOI > 2 mm and ≤ 4 mm, or tumor > 2 cm
but ≤ 4 cm and DOI ≤ 4 mm; T3: tumor > 4 cm or any tumor
DOI > 4 mm.
Statistical analysis was performed using SPSS 24.0.
Univariate and multivariate logistic regression was used
to assess the relationship between T stage (AJCC 7th,
AJCC 8th and our proposal) and the disease-specific sur-
vival (DSS) or disease-free survival (DFS). DSS was de-
fined as the time from surgery to death due to OTSCC or
to the time point of the last follow up. DFS was defined as
the time from surgery to recurrence at the site of the pri-
mary tumor, in neck lymph nodes, or both, or to the time
point of the last follow-up. Survival analysis was also
conducted by Kaplan-Meier analysis and log-rank test.
Hazard ratios (HR) and 95% confidence interval (95%
CI) were calculated by Cox regression. P value < 0.05
was considered statistically significant.
Results
This study includes 165 men and 146 women. One hundred
five tumors were well differentiated, 131 were moderately
differentiated, and 75 tumors were poorly differentiated.
According to the AJCC 7th, 124 cases were of stage T1 and
187 cases were of stage T2. Survival analyses (Table 2) did
not show any statistically significant differences for DSS (HR
1.48, 95% CI 0.87–2.54, P = 0.15) or DFS (HR 0.87, 95% CI
0.57–1.33, P = 0.53) when we analyzed the prognostic value
of T stage in these 311 cases.
When we re-staged the cases according to the criteria of the
AJCC 8th, 90 cases were of stage T1, 201 were of T2, and 20
cases were of T3. Univariate survival analyses showed statis-
tically significant differences in the prognosis of the cases
identified as T3 (Table 2 and Fig. 1). They were associated
with worse DSS (HR 2.21, 95% CI 1.05–4.64, P = 0.036) and
DFS (HR 2.08, 95% CI 1.07–4.01, P = 0.03) compared with
early-stage cases (T1–T2). There was no statistically signifi-
cant difference between T1 and T2 cases. In multivariate anal-
ysis, which includes age of patient, gender, and WHO histo-
logic grade, small tumors (≤ 4 cm in diameter, with cN0)
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identified as T3 (AJCC 8th) were associated with worse DSS
(HR 2.37, 95% CI 1.12–4.99, P = 0.023) and DFS (HR 2.12,
95% CI 1.09–4.08, P = 0.027).
According to our proposal, 32 cases were of stage T1, 118
were of T2, and 161 cases were of stage T3. Survival analyses
(Table 2 and Fig. 2) showed statistically significant differences
and the cases identified as stage T3were associatedwithworse
DSS (HR 3.87, 95% CI 2.10–7.13, P < 0.001) and DFS (HR
1.55, 95% CI 1.01–2.37, P = 0.04). There was no statistically
significant difference between stage T1 and T2 cases. In the
multivariate analysis, cases that were identified as T3 were
associated with worse DSS (HR 4.19, 95% CI 2.27–7.74, P
< 0.001) and DFS (HR 1.62, 95% CI 1.05–2.49, P = 0.029).
The association analysis of age, gender, and WHO histo-
pathologic grade with T stage (AJCC 7th) revealed a signifi-
cant relationship between gender and T stage, as men were
more affected by T2 tumors than women (P = 0.008).
Similarly, applying the AJCC 8th, men were more affected
by T2 and T3 tumors than women (P = 0.02). There was no
significant relationship between T stage (AJCC 7th or AJCC
8th) and age of patients orWHO tumor grade. Our proposed T
stage had a significant association with WHO grade (P =
0.02), but there was no significant relationship between with
age or gender.
Discussion
One of the main aims of the TNM classification is to provide
prognostic information that allows clinician to classify a new-
ly diagnosed case of OTSCC at Blow-risk,^ which will be
managed by surgery only, or at Bhigh-risk,^ which is prone
to receive a treatment based on surgery associated with elec-
tive neck dissection and radiotherapy. The recently revised 8th
edition of AJCC staging manual has incorporated the DOI in
the T stage criteria, with the aim of increase the predictive
power of TNM system. Here, we analyzed the effects of this
modification in a large multicenter cohort of small (≤ 4 cm in
diameter) OTSCC lesions with clinically negative neck. We
found that many cases classified as T1 or T2 stage (early
stage) according to the AJCC 7th become T3 (advanced stage)
according to the AJCC 8th, and these T3 cases have a poor
prognosis compared with T1–T2 cases.
This modification in the T category solved the draw-
back in many cases that had occurred when using the
previously in staging of patients with small OTSCC with
clinically negative neck. Recent studies have reported that
such cases had a high rate of lymph node metastasis,
recurrence, and cancer-related mortality [2, 3]. In our pre-
vious study covering all stages (I–IV) of OTSCC, stage II
Table 1 T staging criteria for small OTSCC (≤ 4 cm in diameter) with clinically negative neck in the AJCC 7th, the AJCC 8th (which incorporated
depth of invasion, DOI (DOI is the measurement of depth of invasion and not tumor thickness)), and our proposal using a lower cutoff point for DOI
T category Criteria in the
AJCC 7th
Criteria in the AJCC 8th Our proposal
T1 Tumor ≤ 2 cm Tumor ≤ 2 cm, ≤ 5 mm DOI Tumor ≤ 2 cm, ≤ 2 mm DOI
T2 Tumor > 2 cm but ≤ 4 cm Tumor ≤ 2 cm, DOI > 5 mm and ≤ 10 mm;
or tumor > 2 cm but ≤ 4 cm, and ≤ 10 mm DOI
Tumor ≤ 2 cm, DOI > 2 mm and ≤ 4 mm;
or tumor > 2 cm but ≤ 4 cm, and ≤ 4 mm DOI
T3 – Tumor > 4 cm or any tumor > 10 mm DOI Tumor > 4 cm or any tumor > 4 mm DOI
Table 2 Survival analysis of 311 cases of small OTSCC (≤ 4 cm in diameter) with clinically negative neck according to the AJCC 7th edition, the
AJCC 8th edition, and our proposal. In the multivariate analyses, T stage was entered into the model comprising age, gender, and WHO grade
Variable Number of cases (%) Disease-specific survival Disease-free survival
Univariate analysis
HR (95% CI), P
Multivariate analysis
HR (95% CI), P
Univariate analysis
HR (95% CI), P
Multivariate analysis
HR (95% CI), P
T stage (AJCC 7th)
T1N0 124 (39.9) 1 1 1 1
T2N0 187 (60.1) 1.48 (0.87–2.54), P = 0.15 1.67 (0.97–2.89), P = 0.08 0.87 (0.57–1.33), P = 0.53 0.91 (0.59–1.40), P = 0.67
T stage (AJCC 8th)
T1–2N0 291 (93.6) 1 1 1 1
T3 20 (6.4) 2.21 (1.05–4.64), P = 0.036 2.37 (1.12–4.99), P = 0.023 2.08 (1.07–4.01), P = 0.03 2.12 (1.09–4.08), P = 0.027
T stage (our proposal)
T1–2N0 150 (48.2) 1 1 1 1
T3 161 (51.8) 3.87 (2.10–7.13), P < 0.001 4.19 (2.27–7.74), P < 0.001 1.55 (1.01–2.37), P = 0.04 1.62 (1.05–2.49), P = 0.029
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patients had a poor survival, which was almost similar to
stage III patients [14]. This indicates understaging in
some stage II cases according to the AJCC 7th [5]. In
such cases, understaging would be solved by applying
the AJCC 8th, which incorporates DOI, and thus
upstaging them from stage T1–T2 to T3.
The AJCC 8th applies a cutoff point of 5 mm DOI for
upstaging from stage T1 to T2 and 10 mm for upstaging to
Fig. 1 Kaplan-Meier curves for DSS (a) and DFS (b) in small OTSCC according to AJCC 8th. DSS, disease-specific survival; DFS, disease-free
survival
Fig. 2 Kaplan-Meier curves for DSS (a) and DFS (b) in small OTSCC according to our proposal. DSS, disease-specific survival; DFS, disease-free
survival
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T3. However, this appears to be problematic as numerous
cases of deeply invasive tumors (> 4 mm to 10 mm DOI) will
remain in stage T1 or T2. It is noteworthy that deep invasion
of > 4 mm carries a risk for locoregional metastasis and is
associated with poor prognosis [3, 7, 8, 13, 15, 16]. Several
recent studies (Table 3) have evaluated the prognostic value of
DOI and reported consistent results with DOI being a prom-
ising prognosticator. Although the cutoff point has varied in
these studies, a value of 4 mm is widely used. Of note, 4 mm
has been also suggested as an optimal cutoff point in a meta-
analysis of OSCC studies [12]. For this reason, we propose for
future discussions regarding the development of the AJCC
staging system that cases with invasive growth deeper than
4 mm should be considered for upstaging to advanced T cat-
egory, i.e., stage T3.
The 8th edition of the AJCC manual states that DOI, not
tumor thickness, must be used for T staging. However, a re-
cent study has reported a similar performance whether using
DOI or tumor thickness for T staging according to AJCC 8th
[17]. Tumor thickness can be evaluated preoperatively by ul-
trasonography [18, 19] and magnetic resonance imaging
[20–23]. On the other hand, it is sometimes difficult to assess
DOI accurately using imaging [1]. In the histopathologic as-
sessment, significant differences between the measurements
of tumor thickness and DOI were noted in only a small num-
ber of cases [17]. In addition, agreement between histologic
measurement and preoperative image measurement of tumor
thickness has been reported inOTSCC [24]. Therefore, further
research should evaluate the incorporation of tumor thickness
as measured by preoperative imaging in the T staging. This
might be more useful for treatment planning than DOI, which
is a histopathologic measurement and accurately assessed on-
ly postoperatively. Importantly, evaluation of DOI in preoper-
ative biopsies requires truly representative samples, which is
sometimes challenging [25].
In conclusion, the new criteria introduced in the AJCC 8th
for T staging reclassified many T1–T2 OTSCCs with cN0 in
our series to T3 (advanced stage), and such cases had a poor
prognosis. The T stage criteria can be further optimized by
considering any tumor > 4 cm in diameter and/or any tumor
with DOI > 4 mm as T3 stage. Larger studies will be needed to
further validate the prognostic value of OTSCC staging ac-
cording to the AJCC 8th edition, and are also necessary to
assess our proposal for re-staging using DOI of 4 mm for
upstaging to T3.
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Table 3 Summary of recent studies published during the last 10 years (2007–2017) and have evaluated the prognostic value of DOI in large cohorts (>
100 cases) of small OSCC with clinically negative lymph nodes
Authors, year Country Cases Stage Location DOI cutoff
point (mm)
Main finding about DOI
Melkane et al. [15], 2012 France 166 cT1–T2N0 OSCC 6.5 The sentinel node (SN) involvement was associated with DOI
(median DOI for SN+ tumors was 6.5 mm).
4 (median DOI for SN− tumors was 4 mm).
Ganly et al. [7], 2012 USA 216 cT1–T2N0 OTSCC 2 DOI is a prognostic factor for NRFS in multivariate analysis.









479 cT1–T2N0 OTSCC 4 DOI is associated with DFS and DSS in multivariate analysis.
Xie et al. [13], 2015 China 106 cT1–T2N0 OTSCC 4 DOI was significantly associated with LN metastasis and OS.
Hakeem et al. [11], 2016 India 176 cT1–T2N0 OTSCC 5 DOI was associated with development of regional recurrence.
Wang et al. [9], 2017 China 144 cT1–T2N0 OSCC 2 DOI was not associated with OS in multivariate analysis.
Arora et al. [8], 2017 India 336 cT1–T2N0 OSCC 4 Patients with a DOI > 4 mm have a high risk of LN
involvement.
DOI, depth of invasion; DSS, disease-specific survival; DFS, disease-free survival; NRFS, neck recurrence-free survival; LN, lymph node; OSCC, oral
squamous cell carcinoma; OTSCC, oral tongue squamous cell carcinoma; SN, sentinel node; OS, overall survival
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